ArticleMedical oncology (Northwood, London, England)2014

Homoharringtonine contributes to imatinib sensitivity by blocking the EphB4/RhoA pathway in chronic myeloid leukemia cell lines.

Bin-Tao Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.